<img src="https://ws.zoominfo.com/pixel/eCRg8hzy2qp0kNUl6E1g" width="1" height="1" style="display: none;">

Clinical Lab Products: Blood-based Approach to PD-L1 Detection Shows Concordance with Immunohistochemistry

From Clinical Lab Products: "Measurement of PD-L1 is challenging not only when tissue is lacking, but due to the inherent complexity of immunohistochemistry,” says Pritchett. “The testing approach demonstrated in this study shows promise as a method of assessing PD-L1 in plasma. A more objective measure of PD-L1 status could offer a path to better patient care decisions in the treatment of non-small cell lung cancer.” - Dr. Michael Pritchett. Read more. 

Dr. Michael Pritchett Dr. Michael Pritchett uses liquid biopsies in his practice.

Topics: PD-L1 testing, liquid biopsy, lung cancer testing, immunohistochemistry, In the News